Stay updated on ZFN Therapeutic SB-318 in MPS I Clinical Trial
Sign up to get notified when there's something new on the ZFN Therapeutic SB-318 in MPS I Clinical Trial page.

Latest updates to the ZFN Therapeutic SB-318 in MPS I Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedAdded a Locations section including California; removed the California Locations entry and the HHS Vulnerability Disclosure; updated the page revision to v3.3.3.SummaryDifference0.2%

- Check53 days agoChange DetectedThe page shows Revision: v3.3.2 replacing v3.3.1, a minor site revision tag that does not affect study content or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check61 days agoChange DetectedPublication sourcing wording updated to 'automatically filled in from PubMed' and the Revision: v3.3.1 tag added. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check68 days agoChange DetectedFunding/operating-status notice has been removed; study details and links remain unchanged.SummaryDifference0.4%

- Check82 days agoChange DetectedThe study details page shows only formatting/layout updates; core study information remains unchanged (eligibility criteria, outcomes, enrollment). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to ZFN Therapeutic SB-318 in MPS I Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ZFN Therapeutic SB-318 in MPS I Clinical Trial page.